High expression of SERPINE1 and STC2 in lung cancer tissues of NSCLC patients (n = 5) and low expression of LPCAT1 in the NSCLC group were confirmed at the mRNA level compared to those in the normal lung tissues (n = 5) (Figure 10). This evidence concerns the gene LPCAT1 and lung cancer.